Abbott Laboratories Inc. said it will stop selling its Absorb bioresorbable vascular scaffold (BVS), citing low commercial sales as the reason for the decision. The Abbott Park, Ill.-based company first received FDA approval for Absorb in July of last year. (See BioWorld MedTech, July 6, 2016.) But a series of setbacks and safety concerns significantly hindered adoption of the technology.